These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7869051)

  • 1. Pocket 4 of the HLA-DR(alpha,beta 1*0401) molecule is a major determinant of T cells recognition of peptide.
    Fu XT; Bono CP; Woulfe SL; Swearingen C; Summers NL; Sinigaglia F; Sette A; Schwartz BD; Karr RW
    J Exp Med; 1995 Mar; 181(3):915-26. PubMed ID: 7869051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the third, but not the first or second, hypervariable regions of DR(beta 1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide.
    Olson RR; De Magistris MT; Di Tommaso A; Karr RW
    J Immunol; 1992 May; 148(9):2703-8. PubMed ID: 1573265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes.
    Tuosto L; Karr RW; Fu XT; Olson RR; Cundari E; Piccolella E; Lechler R; Lombardi G
    Hum Immunol; 1994 Aug; 40(4):312-22. PubMed ID: 7528190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitutions in the HLA-DR alpha chain differentially affect DR7-restricted T-cell recognition of rabies virus antigen.
    Fu XT; Saibara T; Karr RW; Celis E
    Hum Immunol; 1996 Feb; 45(2):111-6. PubMed ID: 8882408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions.
    Karr RW; Panina-Bordignon P; Yu WY; Lanzavecchia A
    J Immunol; 1991 Jun; 146(12):4242-7. PubMed ID: 2040799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition.
    Rosen-Bronson S; Yu WY; Karr RW
    J Immunol; 1991 Jun; 146(12):4264-70. PubMed ID: 2040801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
    McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
    J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition.
    Signorelli KL; Watts LM; Lambert LE
    Cell Immunol; 1995 May; 162(2):217-24. PubMed ID: 7743549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.
    Geluk A; Fu XT; van Meijgaarden KE; Jansen YY; De Vries RR; Karr RW; Ottenhoff TH
    Eur J Immunol; 1994 Dec; 24(12):3241-4. PubMed ID: 7805754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic residues in the DR beta chain third hypervariable region are required for stimulation of a DR(alpha, beta 1*0402)-restricted T-cell clone.
    Olson RR; Reuter JJ; McNicholl J; Alber C; Klohe E; Callahan K; Siliciano RF; Karr RW
    Hum Immunol; 1994 Nov; 41(3):193-200. PubMed ID: 7868374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR beta chain residues that are predicted to be located in the floor of the peptide-binding groove contribute to antibody-binding epitopes.
    Klohe E; Fu XT; Ballas M; Karr RW
    Hum Immunol; 1993 May; 37(1):51-8. PubMed ID: 7690741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
    Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes.
    Fu XT; Karr RW
    Hum Immunol; 1994 Apr; 39(4):253-60. PubMed ID: 7520896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.